Caveolin-1 inhibits anchorage-independent growth, anoikis and invasiveness in MCF-7 human breast cancer cells

Caveolin-1 is an essential structural constituent of caveolae that has been implicated in mitogenic signaling and oncogenesis. Caveolin-1 is down-regulated in oncogene-transformed and tumor-derived cells. Antisense suppression of caveolin-1 or expression of a dominant negative form are sufficient for inducing cellular transformation. Expression of recombinant caveolin-1 inhibits anchorage-independent growth in cancer cells. The present study was designed to determine whether this is caused by inhibition of cancer cell survival or cell proliferation, and to test if another important property of cancer cells, i.e. matrix invasion, is modulated by expression of caveolin. Utilizing MCF-7 human breast adenocarcinoma cells stably transfected with caveolin-1 (MCF-7/Cav1), we demonstrate that caveolin-1 expression decreases MCF-7 cell proliferation rate and markedly reduces their capacity to form colonies in soft agar. The loss of anchorage-independent growth is not associated with stimulation of anoikis; in fact, MCF-7/Cav1 cells exhibit increased survival after detachment as compared with MCF-7 cells, indicating that in these cells caveolin-1 inhibits anoikis. Analysis of matrix metalloprotease release and matrix invasion revealed that expression of caveolin-1 inhibits also these important metastasis-related phenomena. Plating MCF-7 cells on a laminin matrix resulted in activation of ERK1/2, which was dramatically inhibited in MCF-7/Cav1 cells. We conclude that high expression level of caveolin-1 in human breast cancer cells exerts a negative modulatory effect on anchorage-independent growth by inhibiting cell proliferation even though matrix-independent cell survival is enhanced. Caveolin-1 expression inhibits also matrix invasion and blocks laminin-dependent activation of ERK1/2. The inhibitory effect of caveolin-1 on these transformation-dependent processes supports the hypothesis that caveolin-1 acts as a tumor suppressor protein which may impose major phenotypic changes when expressed in human cancer cells.

[1]  G. G. Stokes.  "J." , 1890, The New Yale Book of Quotations.

[2]  J. Folkman,et al.  Role of cell shape in growth control , 1978, Nature.

[3]  D. Gomez,et al.  Ras oncogene mediated induction of a 92 kDa metalloproteinase; strong correlation with the malignant phenotype. , 1988, Biochemical and biophysical research communications.

[4]  G. Riou,et al.  Over‐expression of MDR gene with no dna amplification in a multiple‐drug‐resistant human ovarian carcinoma cell line , 1989, International journal of cancer.

[5]  M. Hansen,et al.  Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. , 1989, Journal of immunological methods.

[6]  G. Martin,et al.  Eicosapentaenoic acid reduces the invasive and metastatic activities of malignant tumor cells. , 1989, Biochemical and biophysical research communications.

[7]  Richard O. Hynes,et al.  Integrins: Versatility, modulation, and signaling in cell adhesion , 1992, Cell.

[8]  M. Hendrix,et al.  RNA genetics of breast cancer: maspin as paradigm. , 1994, Cold Spring Harbor symposia on quantitative biology.

[9]  S. Frisch,et al.  Disruption of epithelial cell-matrix interactions induces apoptosis , 1994, The Journal of cell biology.

[10]  H. Lodish,et al.  Induction of caveolin during adipogenesis and association of GLUT4 with caveolin-rich vesicles , 1994, The Journal of cell biology.

[11]  A. Shtil,et al.  Frequency of metastasis in Syrian hamster tumor cells selected for low levels of "typical" multidrug resistance. , 1994, Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie.

[12]  M. Lisanti,et al.  Oligomeric structure of caveolin: implications for caveolae membrane organization. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[13]  D. Baltimore,et al.  Reduction of caveolin and caveolae in oncogenically transformed cells. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[14]  S. Bates,et al.  Normal p53 status and function despite the development of drug resistance in human breast cancer cells. , 1995, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[15]  F. Vogel,et al.  VIP21-caveolin, a membrane protein constituent of the caveolar coat, oligomerizes in vivo and in vitro. , 1995, Molecular biology of the cell.

[16]  M. Lisanti,et al.  Caveolae purification and glycosylphosphatidylinositol-linked protein sorting in polarized epithelia. , 1995, Methods in enzymology.

[17]  H. Lodish,et al.  Caveolin Isoforms Differ in Their N-terminal Protein Sequence and Subcellular Distribution. IDENTIFICATION AND EPITOPE MAPPING OF AN ISOFORM-SPECIFIC MONOCLONAL ANTIBODY PROBE (*) , 1995, The Journal of Biological Chemistry.

[18]  F. Giancotti,et al.  The Adaptor Protein Shc Couples a Class of Integrins to the Control of Cell Cycle Progression , 1996, Cell.

[19]  Y. Yarden,et al.  ErbB‐2 is a common auxiliary subunit of NDF and EGF receptors: implications for breast cancer. , 1996, The EMBO journal.

[20]  E. Ruoslahti,et al.  Control of adhesion-dependent cell survival by focal adhesion kinase , 1996, The Journal of cell biology.

[21]  A. Mercurio,et al.  A Function for the Integrin α6β4 in the Invasive Properties of Colorectal Carcinoma Cells , 1996 .

[22]  B. Ogretmen,et al.  Expression of the mutated p53 tumor suppressor protein and its molecular and biochemical characterization in multidrug resistant MCF-7/Adr human breast cancer cells , 1997, Oncogene.

[23]  E Ruoslahti,et al.  Integrins and anoikis. , 1997, Current opinion in cell biology.

[24]  Asim Khwaja,et al.  Matrix adhesion and Ras transformation both activate a phosphoinositide 3‐OH kinase and protein kinase B/Akt cellular survival pathway , 1997, The EMBO journal.

[25]  E. V. van Donselaar,et al.  Cell-type and Tissue-specific Expression of Caveolin-2 , 1997, The Journal of Biological Chemistry.

[26]  Charles C. Wykoff,et al.  Recombinant Expression of Caveolin-1 in Oncogenically Transformed Cells Abrogates Anchorage-independent Growth* , 1997, The Journal of Biological Chemistry.

[27]  H. Rubinfeld,et al.  Detection of ERK activation by a novel monoclonal antibody , 1997, FEBS letters.

[28]  Leslie M Shaw,et al.  Activation of Phosphoinositide 3-OH Kinase by the α6β4 Integrin Promotes Carcinoma Invasion , 1997, Cell.

[29]  F. Giancotti,et al.  A Requirement for Caveolin-1 and Associated Kinase Fyn in Integrin Signaling and Anchorage-Dependent Cell Growth , 1998, Cell.

[30]  Jan E Schnitzer,et al.  Tumor cell growth inhibition by caveolin re-expression in human breast cancer cells , 1998, Oncogene.

[31]  M. Lisanti,et al.  Caveolins, a Family of Scaffolding Proteins for Organizing “Preassembled Signaling Complexes” at the Plasma Membrane* , 1998, The Journal of Biological Chemistry.

[32]  J. Engelman,et al.  Expression of caveolin-1 and -2 in differentiating PC12 cells and dorsal root ganglion neurons: caveolin-2 is up-regulated in response to cell injury. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[33]  R. G. Anderson.  The caveolae membrane system. , 1998, Annual review of biochemistry.

[34]  M. Lisanti,et al.  Upregulation of caveolin‐1 and caveolae organelles in Taxol‐resistant A549 cells , 1998, FEBS letters.

[35]  J. Engelman,et al.  Caveolin‐mediated regulation of signaling along the p42/44 MAP kinase cascade in vivo , 1998, FEBS letters.

[36]  G. Fiucci,et al.  Up-regulation of Caveolae and Caveolar Constituents in Multidrug-resistant Cancer Cells* , 1998, The Journal of Biological Chemistry.

[37]  Richard J. Lee,et al.  Reciprocal Regulation of Neu Tyrosine Kinase Activity and Caveolin-1 Protein Expression in Vitro and in Vivo , 1998, The Journal of Biological Chemistry.

[38]  George Reid,et al.  Analysis of the CAVEOLIN-1 gene at human chromosome 7q31.1 in primary tumours and tumour-derived cell lines , 1999, Oncogene.

[39]  E. Feldman,et al.  Caveolin‐1 expression in Schwann cells , 1999, Glia.

[40]  C. Peschle,et al.  Expression of Caveolin-1 Is Required for the Transport of Caveolin-2 to the Plasma Membrane , 1999, The Journal of Biological Chemistry.

[41]  J. Engelman,et al.  Caveolins, Liquid-Ordered Domains, and Signal Transduction , 1999, Molecular and Cellular Biology.

[42]  A. Bist,et al.  Intracellular cholesterol transport in synchronized human skin fibroblasts. , 1999, Biochemistry.

[43]  H. Chapman,et al.  A Role for Caveolin and the Urokinase Receptor in Integrin-mediated Adhesion and Signaling , 1999, The Journal of cell biology.

[44]  L. Campbell,et al.  Caveolin-1 expression and caveolae biogenesis during cell transdifferentiation in lung alveolar epithelial primary cultures. , 1999, Biochemical and biophysical research communications.

[45]  P. Lollini,et al.  The expression of P-glycoprotein is causally related to a less aggressive phenotype in human osteosarcoma cells , 1999, Oncogene.

[46]  J. Couet,et al.  Reduction of caveolin 1 gene expression in lung carcinoma cell lines. , 1999, Biochemical and biophysical research communications.

[47]  J. Engelman,et al.  Sequence and detailed organization of the human caveolin‐1 and ‐2 genes located near the D7S522 locus (7q31.1) , 1999, FEBS letters.

[48]  A. Quest,et al.  Caveolin-1 levels are down-regulated in human colon tumors, and ectopic expression of caveolin-1 in colon carcinoma cell lines reduces cell tumorigenicity. , 2000, Cancer research.

[49]  D. Brenner,et al.  The Focal Adhesion Kinase Suppresses Transformation-associated, Anchorage-independent Apoptosis in Human Breast Cancer Cells , 2000, The Journal of Biological Chemistry.

[50]  A. Sacchi,et al.  Cooperative Signaling between α6β4Integrin and ErbB-2 Receptor Is Required to Promote Phosphatidylinositol 3-Kinase-dependent Invasion* , 2000, The Journal of Biological Chemistry.

[51]  T. Timme,et al.  Caveolin-1 is regulated by c-myc and suppresses c-myc-induced apoptosis , 2000, Oncogene.

[52]  W. Zundel,et al.  Caveolin 1-Mediated Regulation of Receptor Tyrosine Kinase-Associated Phosphatidylinositol 3-Kinase Activity by Ceramide , 2000, Molecular and Cellular Biology.

[53]  Li Zhang,et al.  Ligand Binding to Integrins* , 2000, The Journal of Biological Chemistry.

[54]  Deborah A. Brown,et al.  Structure and Function of Sphingolipid- and Cholesterol-rich Membrane Rafts* , 2000, The Journal of Biological Chemistry.

[55]  M. Liscovitch,et al.  Multidrug resistance: a role for cholesterol efflux pathways? , 2000, Trends in biochemical sciences.

[56]  C. Fielding,et al.  Cholesterol and caveolae: structural and functional relationships. , 2000, Biochimica et biophysica acta.

[57]  K. Okazaki,et al.  Constitutive activation of MAP kinase kinase (MEK1) is critical and sufficient for the activation of MMP-2. , 2000, Experimental cell research.

[58]  M. Drab,et al.  Loss of Caveolae, Vascular Dysfunction, and Pulmonary Defects in Caveolin-1 Gene-Disrupted Mice , 2001, Science.

[59]  T Hayakawa,et al.  Invasion activating caveolin-1 mutation in human scirrhous breast cancers. , 2001, Cancer research.

[60]  P. Gargalovic,et al.  Caveolin-1 and Caveolin-2 Expression in Mouse Macrophages , 2001, The Journal of Biological Chemistry.

[61]  S. Hilsenbeck,et al.  AP-1 blockade inhibits the growth of normal and malignant breast cells , 2001, Oncogene.

[62]  Yan Xu,et al.  Lysophospholipids increase interleukin-8 expression in ovarian cancer cells. , 2001, Gynecologic oncology.

[63]  M. Lisanti,et al.  Caveolin-1 expression negatively regulates cell cycle progression by inducing G(0)/G(1) arrest via a p53/p21(WAF1/Cip1)-dependent mechanism. , 2001, Molecular biology of the cell.

[64]  M. Lisanti,et al.  Caveolin-1 expression sensitizes fibroblastic and epithelial cells to apoptotic stimulation. , 2001, American journal of physiology. Cell physiology.

[65]  B. Spengler,et al.  Reverse transformation of multidrug-resistant cells , 1994, Cancer and Metastasis Reviews.

[66]  R. Reich,et al.  Role of phospholipase D in laminin-induced production of gelatinase A (MMP-2) in metastatic cells , 1995, Clinical & Experimental Metastasis.